Skip to main content
logo
Navin Fluorine International Limited (BOM:532504)
India flag India · Delayed Price · Currency is INR
5,010.50
-32.15 (-0.64%)
At close: Aug 1, 2025

Marinus Pharmaceuticals Revenue

Navin Fluorine International had revenue of 7.25B INR in the quarter ending June 30, 2025, with 38.52% growth. This brings the company's revenue in the last twelve months to 25.51B, up 21.62% year-over-year. In the fiscal year ending March 31, 2025, Navin Fluorine International had annual revenue of 23.49B with 13.77% growth.

Revenue (ttm)
25.51B
Revenue Growth
+21.62%
P/S Ratio
9.65
Revenue / Employee
17.16M
Employees
1,487
Market Cap
246.29B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202523.49B2.84B13.77%
Mar 31, 202420.65B-123.90M-0.60%
Mar 31, 202320.77B6.24B42.94%
Mar 31, 202214.53B2.74B23.23%
Mar 31, 202111.79B1.18B11.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Reliance Industries9,765.41B
HDFC Bank2,736.06B
Bharti Airtel1,839.41B
Tata Consultancy Services2,561.48B
ICICI Bank2,054.85B
State Bank of India3,429.39B
Infosys1,672.76B
Hindustan Unilever639.28B
Revenue Rankings

Navin Fluorine International News

More News